article · Lung India

Unveiling MicroRNA-21 as a non-invasive diagnostic biomarker in chronic obstructive pulmonary disease-associated pulmonary hypertension: Comparative insights with NT-proBNP

Hoda A. Eid
Mona A. Eldosoky
Eman Salah Albeltagy
Rehab M. Hamdy
OMAIMA ABO-ELKHEIR
Mohamed A. Heiba
Esraa Ali
Walaa Shipl
Shahinaz El Attar
Sally S. Abd Elhamed
Asmaa A. Elmadbouly

2026Open accessAin Shams University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

miR-21 may serve as a useful and reliable biomarker for diagnosing PH in COPD patients, outperforming the traditional biomarker NT-proBNP.

Research topics

Pulmonary Hypertension Research and Treatments
Chronic Obstructive Pulmonary Disease (COPD) Research
MicroRNA in disease regulation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.4103/lungindia.lungindia_413_25

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.